Medicaid, the nation’s public health insurance program for low-income people, now covers nearly 60 million Americans, including many working families, as well as many of the poorest and most fragile individuals in the US society.
Aflac is committed to the prevention and treatment of
breast cancer through research, education and collaboration. Throughout the month of October, Aflac goes pink to help raise funds for the American Association for Cancer Research.
This presentation was created for Cover Georgia coalition partners and others who would like to inform their stakeholders and communities about Georgia's coverage gap. Cover Georgia is a coalition of 70+ organizations working to cover Georgia's low-income uninsured by taking advantage of the federal funding made available by the federal govt. to expand Medicaid to all low-income adults.
Domestic Innovative Financing for Health: Learning From Country ExperienceHFG Project
Advances in health care are extending and improving the quality of life for people around the world, but such advances come with a price tag. While all nations face budgetary constraints for health funding, low- and middle-income countries have the fewest resources for their health sectors. And as many of these nations begin transitioning away from donor-funding for health programs, they need to ensure that any financing gaps are not covered by households paying out-of-pocket in a way that increases inequities in health access and pushes more people into poverty. Clearly, there is a need for low- and middle-income countries to increase the flow of equitable and sustainable domestic financing for health.
A new HFG report —Domestic Innovative Financing for Health: Learning From Country Experience—highlights “domestic innovative financing” options; that is, those originating from domestic sources which can generate additional resources for the health sector. The focus of the report is not to prioritize revenue generation, but rather to “assess country experience with domestic innovative financing options, both successes and failures, in order to increase global wisdom on selecting and implementing them in low- and middle-income countries.” It draws on lessons learned from several countries to provide evidence and scenarios for low- and middle-income nations to increase the financing potential of national health systems.
Deborah Erickson, alaska Health Care Commissin, delivered this overview of the State of Alaska\'s response to Federal Health Care Reform at the Sept. 2, 1010, Alaska Provider Forum.
In Spring 2013, we are on the precipice of dramatic, disruptive change in the health field that offers an unprecedented opportunity and challenge to transform health care and population health.
We know that traditional public health approaches along with more and better health care are not enough to improve health outcomes, equity, and cost. We must also:
- implement sustainable, fundamental "upstream" changes that address the root causes of disease and disability; and
- transform the way we deliver health care to ensure access to quality, affordable health care for all.
Enjoy this keynote panel presentation from Larry Cohen of the Prevention Institute, which was presented at the 2013 Annual Leadership Conference, co-sponsored by the Center for Health Leadership (CHL) and the California Pacific Public Health Training Center (CALPACT) at UC Berkeley's School of Public Health.
To learn more about this event, please visit:
http://calpact.org/index.php/en/events/leadership-conference
Learn more about CALPACT:
http://calpact.org/
Learn more about the CHL:
http://chl.berkeley.edu/
Medicaid, the nation’s public health insurance program for low-income people, now covers nearly 60 million Americans, including many working families, as well as many of the poorest and most fragile individuals in the US society.
Aflac is committed to the prevention and treatment of
breast cancer through research, education and collaboration. Throughout the month of October, Aflac goes pink to help raise funds for the American Association for Cancer Research.
This presentation was created for Cover Georgia coalition partners and others who would like to inform their stakeholders and communities about Georgia's coverage gap. Cover Georgia is a coalition of 70+ organizations working to cover Georgia's low-income uninsured by taking advantage of the federal funding made available by the federal govt. to expand Medicaid to all low-income adults.
Domestic Innovative Financing for Health: Learning From Country ExperienceHFG Project
Advances in health care are extending and improving the quality of life for people around the world, but such advances come with a price tag. While all nations face budgetary constraints for health funding, low- and middle-income countries have the fewest resources for their health sectors. And as many of these nations begin transitioning away from donor-funding for health programs, they need to ensure that any financing gaps are not covered by households paying out-of-pocket in a way that increases inequities in health access and pushes more people into poverty. Clearly, there is a need for low- and middle-income countries to increase the flow of equitable and sustainable domestic financing for health.
A new HFG report —Domestic Innovative Financing for Health: Learning From Country Experience—highlights “domestic innovative financing” options; that is, those originating from domestic sources which can generate additional resources for the health sector. The focus of the report is not to prioritize revenue generation, but rather to “assess country experience with domestic innovative financing options, both successes and failures, in order to increase global wisdom on selecting and implementing them in low- and middle-income countries.” It draws on lessons learned from several countries to provide evidence and scenarios for low- and middle-income nations to increase the financing potential of national health systems.
Deborah Erickson, alaska Health Care Commissin, delivered this overview of the State of Alaska\'s response to Federal Health Care Reform at the Sept. 2, 1010, Alaska Provider Forum.
In Spring 2013, we are on the precipice of dramatic, disruptive change in the health field that offers an unprecedented opportunity and challenge to transform health care and population health.
We know that traditional public health approaches along with more and better health care are not enough to improve health outcomes, equity, and cost. We must also:
- implement sustainable, fundamental "upstream" changes that address the root causes of disease and disability; and
- transform the way we deliver health care to ensure access to quality, affordable health care for all.
Enjoy this keynote panel presentation from Larry Cohen of the Prevention Institute, which was presented at the 2013 Annual Leadership Conference, co-sponsored by the Center for Health Leadership (CHL) and the California Pacific Public Health Training Center (CALPACT) at UC Berkeley's School of Public Health.
To learn more about this event, please visit:
http://calpact.org/index.php/en/events/leadership-conference
Learn more about CALPACT:
http://calpact.org/
Learn more about the CHL:
http://chl.berkeley.edu/
A Community Health Worker (CHW) is a frontline public health worker who is a trusted community member with an unusually close understanding of the community served. This is short presentation designed to garner support for CHWs.
You should respond to at least two of your peers by extending- refutin.docxjosee57
You should respond to at least two of your peers by extending, refuting/correcting, or adding additional nuance to their posts.
Post #1
Jenna Horgan
NUR 420
Professor Roberts
January 12, 2023
Who are the clients in Community Health nursing?
Individuals, families, and groups who live in a specific geographic area and may be at risk for health problems or in need of health services are considered clients in community health nursing. People of all ages, from infants to the elderly, as well as those with physical, mental, or social challenges, may be included. The purpose of community health nursing is to promote the health and well-being of the entire community by addressing the health needs of its individual members (Rector & Stanley, 2021). Community health nurses work with clients to identify and address health risks, provide health and wellness education, and connect clients to suitable health services.
What government resources might they be eligible for?
Individuals and families may be eligible for a variety of government resources depending on their circumstances. Some of these resources are intended specifically for people with low incomes or who are experiencing financial hardship, while others are open to anyone who meets certain criteria. Among the resources available to them are (ISPOR, n.d):
1. Medicaid: It is a federal-state partnership program that provides health insurance to low-income individuals and families. Individuals must meet income and asset limits, as well as other requirements, to be eligible.
2. Children's Health Insurance Program (CHIP): It is a federally funded program that provides health insurance to low-income children that are not eligible for Medicaid but cannot afford private health insurance. It provides coverage for a variety of medical services, such as preventive care, doctor visits, hospital stays, and prescription medications. Eligibility is determined by income and family size.
3. Supplemental Nutrition Assistance Program (SNAP): It is also known as food stamps and it provides financial assistance to low-income individuals and families in order for them to purchase food. Income and assets, as well as other factors, determine SNAP eligibility.
4. Temporary Assistance for Needy Families (TANF): This program helps low-income families with children by providing financial assistance as well as other services such as job training and childcare. Income and assets, as well as other factors, determine TANF eligibility.
5. Low Income Home Energy Assistance Program (LIHEAP): It is program funded by the federal government that provides low-income households with financial assistance to help them pay for home energy costs such as heating and cooling. The Department of Health and Human Services (HHS) administers the program, which is intended to assist households that are struggling to pay their energy bills and may face having their service disconnected. Eligibility is determined by income and family size.
What ag.
American Medical Association Alliance's 90th Celebration 6-18-12 Part 2Debbi Ricks
This presentation in three parts was prepared for the 90th Celebration of the American Medical Association Alliance (AMA Alliance) that was held in Chicago, Illinois June 18, 2012. Special thanks to President, Pat Hyer for asking me to create the presentation. Photos and items of interest from each decade from the 1920 thru the 2000 is included as well as photos and items from each of the active state Alliances.
American social protection and welfare 2016Elhem Chniti
This is part of a series of lectures in American civilization for 1st year students of English. The lectures covers the main issues related to American social and health care programs Under the different administrations.
See how Direct Relief collects donated medicines and medical supplies from leading medical manufacturers and healthcare companies, then provides them to a network of more than 1,000 free clinics and health centers for their uninsured and low-income patients.
Also discover how Direct Relief tracks storms and disasters using Google technology and how clinics use Direct Relief's SAP system to order from Direct Relief’s inventory of products based on their patients’ needs.
Direct Relief USA is the largest nonprofit of its kind, and the only non-profit licensed to distribute medicine in all 50 states.
Learn more at http://DirectRelief.org
Participate with support at http://directrelief.org/donate
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
NVBDCP.pptx Nation vector borne disease control program
Final fmap ad may 2010
1. WhOSE QUALITY CARE
CAN YOU hELP PROTECT?
All of them.
The federal medical assistance percentage (FMAP) is providing needed financial
assistance to state Medicaid programs, allowing millions of low-income Americans to
receive the quality care they need and deserve.
During these tough economic times, when state Medicaid programs are underfunded
and state Governors are asking for federal support, patients are the first to feel the
impact of funding cuts.
CONGRESS: PROTECT QUALITY CARE. EXTEND FMAP TO JUNE 30, 2011.
AFL-CIO • American Academy of Pediatrics • American Congress of Obstetricians and Gynecologists • American
Dental Association • American Health Care Association • American Public Health Association • Association of
Clinicians for the Underserved • Association for Community Affiliated Health Plans • Easter Seals • Medicaid
Health Plans of America • National Association of Children’s Hospitals • National Association of Community Health
Centers • National Association of Public Hospitals and Health Systems • National Center for Assisted Living •
National Council for Community Behavioral Healthcare • National Health Care for the Homeless Council
